stt3a (Santa Cruz Biotechnology)
Structured Review

Stt3a, supplied by Santa Cruz Biotechnology, used in various techniques. Bioz Stars score: 93/100, based on 7 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/stt3a/bio_rxiv__64898__2026__02__27__708521-302-71-72?v=Santa+Cruz+Biotechnology
Average 93 stars, based on 7 article reviews
Images
1) Product Images from "ASPARAGINE-RICH METASTATIC NICHES DRIVE PROSTATE CANCER ORGANOTROPISM BY ENABLING TRANSLATIONAL REWIRING TOWARD N-GLYCOSYLATED PROTEINS"
Article Title: ASPARAGINE-RICH METASTATIC NICHES DRIVE PROSTATE CANCER ORGANOTROPISM BY ENABLING TRANSLATIONAL REWIRING TOWARD N-GLYCOSYLATED PROTEINS
Journal: bioRxiv
doi: 10.64898/2026.02.27.708521
Figure Legend Snippet: (A) Western blot analysis of ASNS in metastatic cells isolated from bone (B-M-1, B-M-2) and lung (L-M-1, L-M-2) lesions. Vinculin was used as loading control. The image is representative of three independent experiments. (B) Schematic representation of asparaginyl-tRNA synthetase 1 (NARS1) mechanism of action. (C) NARS1 mRNA levels in PC3 cells following NARS1 silencing. Cells were transfected with NARS1-targeting small interfering RNA (siRNA) or negative control, and mRNA levels were evaluated after 5 days of incubation in 3D cultures (3D-C) by quantitative RT-PCR, using scramble-transfected cells as reference. (D) Relative cell number of PC3 cells silenced for NARS1 and cultured under standard 2D conditions for 5 days in the presence or absence of Asn (0.1 mM). One-way ANOVA with Sidak’s correction. (E-G) Number of putative N-glycosylation sites in proteins encoded by genes up- or down-regulated in metastatic cells derived from bone (E), lung (F), and liver (G) relative to primary tumor (PT). RNA-seq analysis was conducted as described in . Values are expressed relative to total protein number. (H-I) Fractional enrichment of UDP-GlcNAc isotopologues. PC3 cells were grown in 2D or 3D-C for 5 days and subsequently incubated in a medium containing U- 13 C-glucose for 24h. Labeling enrichment was evaluated by LC-MS analysis, and isotopologue abundance is reported as relative to total UDP-GlcNAc amount. Welch’s t test. (J) Labeling (m+5) enrichment of penotose phosphates from U- 13 C-glucose in PC3 cells growing in 2D or 3D-C for 5 days and subsequently incubated in a medium containing U- 13 C-glucose for 24h. Labeling enrichment was evaluated by LC-MS analysis. (K, L, P) Western blot analysis of GFPT1 (K), STT3a (L), and CD44 (P) expression in PC3 cells silenced for GFPT1, STT3a/b, and CD44 respectively after 48h of gene silencing. Vinculin was used as a loading control. The image is representative of three independent experiments. (M) Concanavalin A lectin binding assay performed on lysates from PC3 cells silenced or not for GFPT1 or STT3a/b and cultured in 3D-C for 5 days. Immunoblot for vinculin was used to confirm equal protein loading across samples. The image is representative of three independent experiments. (N-O) Adhesion of PC3 3D-C to collagen type I (L) and hyaluronic acid (M). Cells were cultured with Asn (0,1 mM) for 5 days and allowed to adhere for 15 min to plates coated with matrix components as reported. Adherent cells were quantified and data are shown relative to untreated cells. Welch’s t-test.
Techniques Used: Western Blot, Isolation, Control, Transfection, Small Interfering RNA, Negative Control, Incubation, Quantitative RT-PCR, Cell Culture, Glycoproteomics, Derivative Assay, RNA Sequencing, Labeling, Liquid Chromatography with Mass Spectroscopy, Expressing, Binding Assay
Figure Legend Snippet: (A-C) Number of putative N-glycosylation sites in proteins encoded by genes upregulated in bone-(A), lung-(B), and liver-(C) derived metastatic cells relative to the primary tumor (PT). RNA-seq analysis was conducted as described in . Values are expressed as relative to proteins number. Welch’s t-test. (D) Number of putative N-glycosylation sites in proteins encoded by genes upregulated in bone-, lung-, and liver-derived metastatic cells. One-way ANOVA with Tukey’s correction. (E) Relative incorporation of U- 13 C-glucose carbons in UDP-N-acetyl-glucosamine. PC3 cells were grown in 3D-C for 5 days and subsequently incubated in a medium containing U- 13 C-glucose for 24h. Metabolite abundance and labeling enrichment were evaluated by LC-MS analysis. (F) mRNA levels of oligosaccharyltransferase (OST) in 2D coltures and 3D-C. mRNA expression levels analyzed by quantitative RT-PCR using 2D condition as comparator. Student’s t test. (G) Concanavalin A lectin binding assay performed on lysates from PC3 cells cultured in 2D conditions or 3D-C, with or without Asn supplementation (0.1 mM). Immunoblot for actin was used to confirm equal protein loading across samples. The image is representative of three independent experiments. (H) Concanavalin A lectin binding assay performed on lysates from 3D-C cultured with or without Asn (0.1 mM) in the presence or absence of L-asparaginase (ASNase, 0.25 U/ml). Immunoblot for vinculin was used to confirm equal protein loading across samples. The image is representative of three independent experiments. (I) Total spheroid area of PC3 3D-C grown with or without Asn (0.1 mM) in the presence or absence of Tunicamycin (5ng/µl). One-way ANOVA with Dunnett’s correction. (J) Total spheroid area of Glutamine-fructose-6-phosphate transaminase 1 (GFPT1)-silenced PC3 cells grown in 3D-C with or without Asn (0.1 mM). One-way ANOVA with Dunnett’s correction. (K) Total spheroid area of 3D-C PC3 cells silenced for the OST catalytic subunits STT3A and STT3B with or without Asn (0.1 mM). One-way ANOVA with Dunnett’s correction. (L) Concanavalin A lectin binding assay performed on lysates from liver-derived (Liv-M), bone-derived (B-M-1, B-M-2) and lung-derived (L-M-1, L-M-2) metastatic cells (obtained after intracardiac or caudal artery injection, respectively) grown in 3D-C cultures. Immunoblot for vinculin was used to confirm equal protein loading across samples. The image is representative of three independent experiments. (M-P) Total spheroid area of bone-derived (M, N), and lung-derived (O, P) metastatic cells grown in 3D-C cultures with or without Asn (0.1 mM) in the presence or absence of Tunicamycin (5ng/µl). Two-way ANOVA with Tukey’s correction. ns, not significant; *P < 0.05; **P < 0.01; ***P < 0.001; ****P < 0.0001. Data represent mean ± s.e.m. from at least three independent experiments.
Techniques Used: Glycoproteomics, Derivative Assay, RNA Sequencing, Incubation, Labeling, Liquid Chromatography with Mass Spectroscopy, Expressing, Quantitative RT-PCR, Binding Assay, Cell Culture, Western Blot, Injection
